Recent developments in the field of vascular liver diseases

被引：3

作者：

Valla, Dominique C. ^{[1
,2
]}

机构：

[1] Univ Paris, Hop Beaujon, AP HP, Serv Hepatol, 100 Blvd Leclerc, Clichy La Garenne 92118, France

[2] INSERM, 100 Blvd Leclerc, Clichy La Garenne 92118, France

来源：

LIVER INTERNATIONAL | 2020年 / 40卷

关键词：

anticoagulants; cirrhosis; congenital extrahepatic portsystemic shunt; direct oral anticoagulants; non-specific beta blockers; portal flow velocity; portal hypertension; portal vein thrombosis; PORTAL-VEIN THROMBOSIS; INTRAHEPATIC PORTOSYSTEMIC SHUNT; NONSELECTIVE BETA-BLOCKERS; ORAL ANTICOAGULANTS; VENOUS THROMBOSIS; CIRRHOSIS; RISK; MANAGEMENT; EFFICACY; IMPACT;

D O I：

10.1111/liv.14348

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Knowledge in the field of vascular liver disease is continuously expanding. The present update will discuss recent data on i) the Abernethy malformation in adults; ii) portal vein thrombosis in cirrhosis; iii) advancing expertise in recanalization of the portal vein and iv) experience in using direct oral anticoagulants in the field of vascular liver disease.

引用

页码：142 / 148

页数：7

共 50 条

[21] Recent advances in the management of pediatric cholestatic liver diseases
Mysore, Krupa R.
Cheng, Katherine
Suri, Lakshmi Anandini
Fawaz, Rima
Mavis, Alisha M.
Kogan-Liberman, Debora
Mohammad, Saeed
Taylor, Sarah A.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2025, : 549 - 558
[22] Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver
Martin-Llahi, Marta
Albillos, Agustin
Banares, Rafael
Berzigotti, Annalisa
Angeles Garcia-Criado, M.
Genesca, Joan
Hernandez-Gea, Virginia
Llop-Herrera, Elba
Masnou-Ridaura, Helena
Mateo, Jose
Navascues, Carmen A.
Puente, Angela
Romero-Gutierrez, Marta
Simon-Talero, Macarena
Tellez, Luis
Turon, Fanny
Villanueva, Candid
Zarrabeitia, Roberto
Carlos Garcia-Pagan, Juan
GASTROENTEROLOGIA Y HEPATOLOGIA, 2017, 40 (08): : 538 - 580
[23] COVID-19 and liver diseases
Elghannam, Maged T.
Hassanien, Moataz H.
Ameen, Yosry A.
ELattar, Gamal M.
ELRay, Ahmed A.
Turky, Emad A.
ELTalkawy, Mohammed D.
EGYPTIAN LIVER JOURNAL, 2022, 12 (01)
[24] Review article: thromboelastography in liver diseases
He, Yanglan
Yao, Haijuan
Ageno, Walter
Mendez-Sanchez, Nahum
Guo, Xiaozhong
Qi, Xingshun
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (04) : 580 - 591
[25] Coagulopathy in Liver Diseases: Complication or Therapy?
Bianchini, Marcello
De Pietri, Lesley
Villa, Erica
DIGESTIVE DISEASES, 2014, 32 (05) : 609 - 614
[26] Adiponectin: A multitasking player in the field of liver diseases
Silva, T. E.
Colombo, G.
Schiavon, L. L.
DIABETES & METABOLISM, 2014, 40 (02) : 95 - 107
[27] The undertreatment of alcohol-related liver diseases among people with alcohol use disorder
Scafato, E.
Caputo, F.
Patussi, V.
Balbinot, P.
Addolorato, G.
Testino, G.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (02) : 974 - 982
[28] Liver diseases and pulmonary vascular disorders
Riou, M.
Jutant, E. -M.
Mignard, X.
Canuet, M.
Humbert, M.
Sitbon, O.
Savale, L.
Montani, D.
REVUE DE MEDECINE INTERNE, 2018, 39 (12): : 925 - 934
[29] Diabetes Association with Liver Diseases: An Overview for Clinicians
Hamed, Abd Elkhalek
Elwan, Nadia
Naguib, Mervat
Elwakil, Reda
Esmat, Gamal
El Kassas, Mohamed
Abd-Elsalam, Sherief
Moussa, Shorouk
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2019, 19 (03) : 274 - 280
[30] Periprocedural management of hemostatic alterations in patients with cirrhosis and vascular liver disorders: a step forward of the American Association for the Study of Liver Diseases
Fortea, Jose Ignacio
Puente, Angela
Crespo, Javier
Fabrega, Emilio
HEPATOBILIARY SURGERY AND NUTRITION, 2023, 12 (01) : 105 - 109

← 1 2 3 4 5 →